Supernus Pharmaceuticals Inc (SUPN)
R&D Expenses
$126.09M
TTM · Period ending: · USD
SUPN R&D Expenses
Latest reported$126.09Mperiod ending
Latest reported$126.09Mperiod ending
SUPN TTM R&D Expenses ($30.63M → $126.09M)
TTM R&D Expenses
High-resolution chart · PNG
SUPN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 126,094,000 | |
| 118,746,000 | |
| 106,235,000 | |
| 107,055,000 | |
| 106,725,000 | |
| 110,793,000 | |
| 108,796,000 | |
| 103,496,000 | |
| 97,115,000 | |
| 95,311,000 | |
| 91,593,000 | |
| 86,020,000 | |
| 82,919,000 | |
| 74,925,000 | |
| 74,552,000 | |
| 77,856,000 | |
| 77,956,000 | |
| 77,026,000 | |
| 90,467,000 | |
| 87,327,000 | |
| 84,512,000 | |
| 91,304,000 | |
| 75,961,000 | |
| 77,815,000 | |
| 77,919,000 | |
| 72,642,000 | |
| 69,099,000 | |
| 79,148,000 | |
| 82,627,000 | |
| 85,695,000 | |
| 89,209,000 | |
| 75,541,000 | |
| 68,099,000 | |
| 58,884,000 | |
| 49,577,000 | |
| 46,656,000 | |
| 41,544,000 | |
| 41,830,000 | |
| 42,791,000 | |
| 38,985,000 | |
| 40,246,000 | |
| 36,015,000 | |
| 29,136,000 | |
| 25,462,000 | |
| 20,990,000 | |
| 18,789,000 | |
| 19,588,000 | |
| 19,218,000 | |
| 18,340,000 | |
| 17,205,000 | |
| 17,245,000 | |
| 16,993,000 | |
| 21,520,000 | |
| 22,681,000 | |
| 23,517,000 | |
| 25,867,000 | |
| 25,986,000 | |
| 28,534,000 | |
| 30,627,000 | |
| 32,196,298 | |
| 31,227,180 |